MCP1逆转了FGF23和欧米茄6/3比率之间的相关性:这是否也适用于移植?
Deborah Mattinzoli1, Stefano Turolo2, Masami Ikehata1
1Renal Research Laboratory, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, 20122 Milan, Italy.
Journal of clinical medicine
|September 28, 2023
概括
纤维细胞生长因子 (FGF23) 在移植 (KTx) 患者中增加,但单细胞化学吸引蛋白1 (MCP1) 水平下降. 多不和脂肪酸 (PUFA) 概况发生变化,在KTx患者中观察到较低的n-6/n-3比率.
科学领域:
- 腎臟病學 (nephrology) 是一種醫學.
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
背景情况:
- 纤维细胞生长因子 (FGF23) 在慢性病 (CKD) 进展期间增加.
- 在晚期CKD中,FGF23和omega-6 (n-6) 多不和脂肪酸 (PUFA) 之间的正相关性出现.
- 以前的研究探讨了FGF23和单细胞化学吸引蛋白1 (MCP1) 在CKD相关的脂质不良和心血管风险中的作用.
研究的目的:
- 在移植 (KTx) 患者中重新评估FGF23,MCP1和PUFA之间的关系.
- 为了研究这些关系的潜在修改,由于特定于KTx队列的因素.
- 了解免疫抑制对这些生物标志物的影响.
主要方法:
- 研究了40名移植患者 (KTx).
- 使用ELISA和气体染色学评估MCP1,FGF23和PUFA水平.
- 分析了FGF23,MCP1和各种n-6和n-3PUFA之间的相关性.
主要成果:
- 在KTx患者中,FGF23水平显著增加 (p < 0.0001).
- 发现MCP1水平较低,与基于CKD进展的预期相反.
- 观察到n-6/n-3PUFA比率下降 (p = 0.042),这是由增加的n-3脂肪酸驱动的.
- 在CKD4期FGF23和n-6/n-3比率之间发现了负相关性 (r2 -0.3,p = 0.043),但与MCP1.1没有相关性.
结论:
- 不同的生物机制可能控制CKD与KTx患者的FGF23,PUFA和MCP1关系.
- 观察到的差异可能与KTx患者的免疫抑制状态有关.
- 需要进一步的研究来阐明这些复杂的相互作用.
相关概念视频
Renal Corpuscle
The glomerulus and Bowman's capsule are two essential components of the nephron, which is the functional unit of the kidney. These microscopic structures play a critical role in the process of blood filtration to produce urine.
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous capillaries...
Kidney Transplant I: Introduction
A kidney transplant is a surgical approach that involves replacing a non-functioning kidney with a healthy one from a donor. This procedure is often a treatment option for end-stage renal disease (ESRD) patients. The method requires careful recipient selection, including evaluating various medical and psychosocial factors. These criteria vary between transplant centers but generally include assessments of the patient's overall health, adherence to medical recommendations, and lifestyle...


